Recently, NUDT15 R139C has been identified as a crucial Asian-prevalent DNA variant that strongly predisposed patients to AZA-related leukopenia during IBD treatment, resulting in reduced dose tolerance [14, 15]. The gene discussed is NUDT15; the disease is inflammatory bowel disease.